JAMES PORTER
Barber in Boston, MA
License number
Massachusetts 703595
Issued Date
Nov 17, 2012
Expiration Date
Dec 31, 2017
Type
Apprentice Barber
Address
Address
Boston, MA 02118
Professional information
Global Customer Service Professional
Location:
Greater Boston Area
Industry:
Semiconductors
Work:
Danaher Corporation - Sonix
- Springfield, VA Feb 2012 - Apr 2013
-
Global Customer Service Manager
JPSA Laser
Feb 2010 - Feb 2012
-
Worldwide Customer Support Manager
BlueShift Technologies
Mar 2008 - Nov 2009
-
Director of Technical and Customer Support
CAMECA
1998 - 2008
-
Global Product Support Manager
Praxair
1997 - 1998
-
Lead Technician
Technical Operations Division
1996 - 1998
-
NDC&A Gas Separations and Measurements
Education:
University of Phoenix 2003 - 2005
BSBM, Double Major; Management and Marketing Community College of the US Air Force 1994 - 1997
State University of New York - System 1991 - 1994
BSBM, Double Major; Management and Marketing Community College of the US Air Force 1994 - 1997
State University of New York - System 1991 - 1994
Skills:
R&D, Product Management, Automation, AC/DC, UHV, ERP, CRM, Project Management, Semiconductors, Product Development, Manufacturing, Management, Process Improvement, Electronics, Engineering Management, Engineering, Laser, Continuous Improvement, Six Sigma, Metrology, Process Engineering, Operations Management, Sales Process, Sales Management, Salesforce.com, CRM databases, Sales Presentations, International Sales, International Relations, International Business, International Development, Sales Operations
Application Engineer At Wilmer Cutler Pickering Hale And Dorr Llp
Position:
Application Engineer at Wilmer Cutler Pickering Hale and Dorr LLP
Location:
Greater Boston Area
Industry:
Legal Services
Work:
Wilmer Cutler Pickering Hale and Dorr LLP
- Greater Boston Area since Jul 2011
-
Application Engineer
Angell Palmer & Dodge LLP
Sep 2007 - Jul 2011
-
Applications Specialist
Edwards Angell Palmer & Dodge LLP
Aug 2004 - Sep 2007
-
Information Technology Specialist
Education:
Suffolk University 2009
Bachelor of Science, Physics CompuCollege School of Business, Halifax 2000
Diploma earned, Information Systems Administrator Barrington High School 1996 - 1999
High School
Bachelor of Science, Physics CompuCollege School of Business, Halifax 2000
Diploma earned, Information Systems Administrator Barrington High School 1996 - 1999
High School
Languages:
English
Senior Director Of Product Development At Infinity Pharmaceuticals, Inc
Position:
Associate Director, Pharmaceutical Development at Infinity Pharmaceuticals, Inc
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Infinity Pharmaceuticals, Inc
-
Associate Director, Pharmaceutical Development
Marketing Associate At Sysco Food Service Of Hallsmith
Position:
Marketing Associate at Sysco Food service of Hallsmith
Location:
Greater Boston Area
Industry:
Food & Beverages
Work:
Sysco Food service of Hallsmith
-
Marketing Associate
Education:
University of Delaware 1992 - 1996
Isoxazolidine Compounds For Treatment Of Bacterial Infections
US Patent:
2006002, Jan 26, 2006
Filed:
Jun 17, 2005
Appl. No.:
11/155314
Inventors:
Burton Christensen - Alamo CA, US
Michael Foley - Chestnut Hill MA, US
Asimina Georges Evangelinos - Andover MA, US
Tao Liu - Ashland MA, US
James Porter - Brighton MA, US
Amy Ripka - Winthrop MA, US
Linping Zhang - Lexington MA, US
Michael Foley - Chestnut Hill MA, US
Asimina Georges Evangelinos - Andover MA, US
Tao Liu - Ashland MA, US
James Porter - Brighton MA, US
Amy Ripka - Winthrop MA, US
Linping Zhang - Lexington MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/42, C07D 261/10, C07D 261/12, C07D 413/02
US Classification:
514378000, 548240000, 548243000
Abstract:
The present invention relates to antibiotic compounds and intermediates useful in their preparation. Many of the antibiotic compounds contain a substituted isoxazolidine ring. The invention also relates to pharmaceutical compositions containing a compound of the invention. The invention further provides processes for the preparation of compounds of the invention, and methods for their use as therapeutic agents.
Analogs Of Benzoquinone-Containing Ansamycins And Methods Of Use Thereof
US Patent:
7282493, Oct 16, 2007
Filed:
Dec 23, 2004
Appl. No.:
11/022057
Inventors:
Julian Adams - Boston MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 225/06, C07D 211/60, C07D 498/08, A61K 31/395, A61K 35/00
US Classification:
514183, 5142298, 514375, 540456, 540461, 540462
Abstract:
The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
Cyclopamine Analogues And Methods Of Use Thereof
US Patent:
7230004, Jun 12, 2007
Filed:
Aug 26, 2005
Appl. No.:
11/213534
Inventors:
Julian Adams - Boston MA, US
Alfredo C. Castro - Winchester MA, US
Michael A. Foley - Chestnut Hill MA, US
Somarajan Nair Janardanan Nair - Belmont MA, US
Marta Nevalainen - Quincy MA, US
James R. Porter - Brighton MA, US
Martin R. Tremblay - Melrose MA, US
Alfredo C. Castro - Winchester MA, US
Michael A. Foley - Chestnut Hill MA, US
Somarajan Nair Janardanan Nair - Belmont MA, US
Marta Nevalainen - Quincy MA, US
James R. Porter - Brighton MA, US
Martin R. Tremblay - Melrose MA, US
Assignee:
Infinity Discovery, Inc. - Cambridge MA
International Classification:
A61K 31/438, A61K 31/4355, C07D 491/10, C07D 491/048
US Classification:
514278, 546 18, 546 15
Abstract:
The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.
Analogs Of Benzoquinone-Containing Ansamycins And Methods Of Use Thereof
US Patent:
7375217, May 20, 2008
Filed:
Apr 14, 2005
Appl. No.:
11/108165
Inventors:
Julian Adams - Boston MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 225/06
US Classification:
540456, 540461, 540462
Abstract:
The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
Cyclopamine Analogues And Methods Of Use Thereof
US Patent:
7407967, Aug 5, 2008
Filed:
Apr 18, 2007
Appl. No.:
11/737035
Inventors:
Julian Adams - Boston MA, US
Alfredo C. Castro - Winchester MA, US
Michael A. Foley - Chestnut Hill MA, US
Somarajan Nair Janardanan Nair - Belmont MA, US
Marta Nevalainen - Quincy MA, US
James R. Porter - Brighton MA, US
Martin R. Tremblay - Melrose MA, US
Alfredo C. Castro - Winchester MA, US
Michael A. Foley - Chestnut Hill MA, US
Somarajan Nair Janardanan Nair - Belmont MA, US
Marta Nevalainen - Quincy MA, US
James R. Porter - Brighton MA, US
Martin R. Tremblay - Melrose MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/4355, C07D 491/048
US Classification:
514302, 546115, 546 15, 514278
Abstract:
The present invention provides compositions and methods for modulating smoothened-dependent pathway activation. The present invention provides analogs of cyclopamine that can be used to counteract the phenotypic effects of unwanted activation of a hedgehog pathway, such as resulting from hedgehog gain-of-function, Ptc loss-of-function or smoothened gain-of-function mutations. The compounds of the present invention are particularly useful in treating cancers.
Analogs Of Benzoquinone-Containing Ansamycins And Methods Of Use Thereof
US Patent:
7361647, Apr 22, 2008
Filed:
Apr 14, 2005
Appl. No.:
11/107404
Inventors:
Julian Adams - Boston MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Yun Gao - Southborough MA, US
Asimina T. Georges Evangelinos - Chestnut Hill MA, US
Louis Grenier - Brookline MA, US
Roger H. Pak - Boxborough MA, US
James R. Porter - Brighton MA, US
James L. Wright - Lexington MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 225/06, C07D 211/60, C07D 498/08, A61K 31/395, A61K 35/00
US Classification:
514183, 5142298, 514375, 540456, 540461, 540462
Abstract:
The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.